Curecell offers consultations to assess whether GHK-Cu peptide therapy fits your skin or wellness goals, backed by licensed medical oversight from start to finish
No validated human clinical dose exists for either compound
Research published in Biochemical Pharmacology demonstrates GHK-Cu activating integrin signaling, upregulating nerve growth factor (NGF), and engaging decorin pathways that organize newly synthesized collagen into functional extracellular matrix architecture
This drug combination is considered standard treatment for PD symptoms such as tremor, muscle stiffness, and slowness of movement
Z68.30 BMI 30.0-30.9, adult Z68.31 BMI 31.0-31.9, adult Z68.32 BMI 32.0-32.9, adult Z68.33 BMI 33.0-33.9, adult Z68.34 BMI 34.0-34.9, adult Z68.35 BMI 35.0-35.9, adult Z68.36 BMI 36.0-36.9, adult Z68.37 BMI 37.0-37.9, adult Z68.38 BMI 38.0-38.9, adult Z68.39 BMI 39.0-39.9, adult Z68.41 BMI 40.0-44.9, adult Z68.42 BMI 45.0-49.9, adult Z68.43 BMI 50.0-59.9, adult Z68.44 BMI 60.0-69.9, adult Z68.45 BMI 70 or greater, adult Note: For pediatric patients aged 2-19 years, BMI percentiles are used: Z68.51 BMI less than 5th percentile for age Z68.52 BMI 5th percentile to less than 85th percentile for age Z68.53 BMI 85th percentile to less than 95th percentile for age Z68.54 BMI greater than or equal to 95th percentile for age 3
Because the needles are so fine (29G-31G), they are unlikely to be significantly dulled by a single puncture of the vials rubber stopper
